aap Implantate AG / Key word(s): Capital Increase
28.04.2011 16:28
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
The Management Board of aap Implantate AG, a medical technology company
listed on the Frankfurt stock exchange in the Prime Standard segment,
decided today with the Supervisory Board's approval to increase its capital
stock from authorized capital by EUR 2,788,186. This corresponds to approx.
10% of the present capital stock. The 2,788,186 new shares are subscribed,
excluding rights entitlement for existing shareholders, by way of a private
placement in return for a cash contribution at a price of EUR 1.09 per
no-par share. The company's capital stock thereby increases by EUR
2,788,186 from the present EUR 27,881,870 to EUR 30,670,056.
The inflow of funds of approx. EUR 3 million from the capital increase is
to serve the purpose of funding further growth by launching new products
and entering new markets in Europe and the United States of America as well
as strengthening the financial basis of aap.
28.04.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: info@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: aap Implantate AG: Capital Increase of approx. 10%
| Source: EQS Group AG